• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager
• BL Club
• Smartbuy

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

P.S. Sundar

Coonoor, Nov. 16 Pharmaceutical companies are stepping up their purchase of Nilgiri green tea for medicine manufacture, producers contend.

Green tea is manufactured by steaming, rolling and drying of tea leaves. There is no fermentation unlike in black tea manufacture. So, the green tea brew is light. Green tea is, therefore, said to retain more therapeutic values of tea.

Researchers have proved that green tea is a potent source for healing anti-oxidants helping to fight cancer, cholesterol, blood pressure, dental and gum decay, indigestion and diarrhoea. So, pharmaceutical industry is keen to source quality green tea.

“Pharmaceutical industry is unable to extract from Chinese tea adequate quality of polyphenols required for drug manufacture. Hence, it is stepping up purchases of our green teas,” saidMr M.N. Bopanna, Managing Director, Craigmore Plantations (I) Ltd, told Business Line.

More Stories on : Tea | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line